Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: A pilot study

Pediatric Pulmonology

Volumn 32, Issue 1, 2001, Pages 29-37

  Ordoñez, Claudia L ^a,b   Stulbarg, Michael ^c   Grundland, H ^c   Liu, Jane T ^c   Boushey, Homer A ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cystic fibrosis; Inflammation; Inflammatory marker; Macrolides; Sputum induction

Indexed keywords

CLARITHROMYCIN; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MACROLIDE; MYELOPEROXIDASE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ATYPICAL MYCOBACTERIUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; HUMAN; INFLAMMATION; LUNG FUNCTION; MALE; NEUTROPHIL; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; REPRODUCIBILITY; SINGLE BLIND PROCEDURE; SPIROMETRY; SPUTUM ANALYSIS;

ADULT; AIRWAY OBSTRUCTION; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CLARITHROMYCIN; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; INTERLEUKIN-8; LEUKOCYTE ELASTASE; MALE; NEUTROPHILS; PEROXIDASE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; SINGLE-BLIND METHOD; SPUTUM; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034961483     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.1085     Document Type: Article

References (43)

1. Prevalence of mucoid strains of Pseudomonas aeruginosa in bacteriological specimens from patients with cystic fibrosis and patients with other diseases
2. Pseudomonas colonization in cystic fibrosis: A study of 160 patients
3. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: Current status of the host-bacterium interaction
4. Inflammatory cytokines in cystic fibrosis lungs
5. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis
6. Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis
7. Sputum tumor necrosis factor-α and leukotriene concentrations in cystic fibrosis
8. Eicosapentaenoic acid in cystic fibrosis: Evidence of a pathogenetic role for leukotriene B4
9. TNF-a, IL-8, soluble ICAM-1, and neutrophils in sputum of cystic fibrosis patients
10. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum and sera of children with cystic fibrosis
11. Anti-inflammatory activity of macrolides: A new therapeutic potential?
12. Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils
13. Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro
14. Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: A potential mechanism of its anti-inflammatory action
15. Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells
16. Excessive accumulation of mucus in children with asthma: A potential role for erythromycin? A case discussion
17. Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections
18. Clinical effect of low-dose, long-term erythromycin chemotherapy on diffuse panbronchiolitis
19. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: A potential mechanism of macrolide therapy
20. Neutrophil chemotactic activity in cryptogenic organizing pneumonia and the response to erythromycin
21. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: A double-blind, placebo-controlled study
22. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells
23. Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection
24. The macrolide antibacterial roxithromycin reduces bronchial hyper-responsiveness and superoxide anion production by polymorphonuclear leukocytes in patients with asthma
25. Effects of roxithromycin and erythromycin on interleukin 8-induced neutrophil recruitment and goblet cell secretion in guinea pig tracheas
26. Biofilm disease: Its clinical manifestation and therapeutic possibilities of macrolides
27. Long-term azithromycin may improve lung function in children with cystic fibrosis
28. Use of induced sputum cell counts to investigate airway inflammation in asthma
29. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects
30. Indices of airway inflammation in induced sputum: Reproducibility and validity of cell and fluid phase measurements
31. Cellular characterisation of sputum from patients with asthma and chronic bronchitis
32. Cellular profiles in asthmatic airways: A comparison of induced sputum, bronchial washings and bronchoalveolar lavage fluid
33. Comparison of inflammatory cell counts in asthma: Induced sputum vs. bronchoalveolar lavage and bronchial biopsies
34. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects
35. Comparison of leucocyte counts in sputum, bronchial biopsies and bronchoalveolar lavage
36. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects
37. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment
38. Chronic cough with eosinophilic bronchitis and examination for variable airflow obstruction and response to corticosteroids
39. Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis
40. Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors
41. Simplified microimmunofluorescence test with trachoma-lympho-granuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody
42. Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection
43. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects